Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-03-04 @ 7:49 PM
Study NCT ID:
NCT03330405
Status:
TERMINATED
Last Update Posted:
2023-10-13
First Post:
2017-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-16
First Submit QC Date:
None
Study First Post Date:
2017-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-10
Results First Submit QC Date:
None
Results First Post Date:
2023-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-11
Last Update Post Date:
2023-10-13
Last Update Post Date Type:
ACTUAL